Search results
Controversial Alzheimer's drug, explained: What to know about Aduhelm, FDA and scathing report
USA TODAY via Yahoo News· 1 year agoThe Food and Drug Administration’s approval process of Alzheimer’s drug Aduhelm has been deemed...
House investigation faults FDA approval of Alzheimer’s drug Aduhelm as ‘rife with irregularities’
The Hill via Yahoo News· 1 year agoThe Food and Drug Administration’s (FDA) process for approving a controversial Alzheimer’s drug with...
Biogen drops Alzheimer's drug Aduhelm, ending a 17-year chapter
Reuters via Yahoo Finance· 3 months agoThe drugmaker said on Wednesday it was concerned that by the time Aduhelm received a standard...
Biogen will stop selling its controversial Alzheimer's drug Aduhelm
Associated Press via AOL· 3 months agoBiogen will stop selling its Alzheimer’s treatment Aduhelm, a drug once seen as a potential...
House investigation finds FDA, drug firm Biogen ignored internal concerns for Alzheimer's drug
ABC News via Yahoo News· 1 year agoA congressional investigation into the Food and Drug Administration's review process for an...
Biogen scraps controversial Alzheimer's drug Aduhelm
CBS MoneyWatch via Yahoo Finance· 3 months agoBiogen is pulling the plug on the controversial drug Aduhelm, the first drug cleared by government health officials for treating Alzheimer's in nearly...
Biogen Rises As 'Relatively Benign' FDA Documents Suggest An Alzheimer's Approval Is Near
Investor's Business Daily· 11 months agoBiogen stock bounded higher Wednesday after the Food and Drug Administration posted "relatively...
Biogen's Turnaround Is Still Waiting In The Wings As Aduhelm Pressures Continue
Investor's Business Daily· 3 months agoBiogen's turnaround is still a "work in progress," an analyst said Tuesday as Biogen stock slumped...
Biogen Inc. (BIIB) Down 4.8% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 2 years agoIt has been about a month since the last earnings report for Biogen Inc. (BIIB). Shares have lost...
How Does Lilly's Alzheimer's Drug Compare to Aduhelm and Leqembi?
Verywell Health via Yahoo News· 1 year agoEli Lilly shared phase 3 clinical trial data showing that a new monoclonal antibody treatment can...